There were 206 male patients in this study with criteria being ≥ 50 years of age as well as an IPSS score of ≥ 13. The prostate vol-ume had to be between 30-80cc and the peak flow rate ≤ 12 ml/s. Pa-tients were randomized to either PUL or control. Both the patients and the assessors were blinded to treatment arm for 3 months. After PUL, a minimally invasive surgery, is implemented, permanent im-plants retract the lateral loves to open the prostatic fossa enlarging the uretheral lumen.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Presented By: Claus Roehrborn, MD
Authors: Claus Roehrborn, MD, Neal Shore, Steven Gange, Daniel B Rukstalis,
Affiliation: UT Southwestern Medical Center, Atlantic Urology Clin-ics, Department of Urology, Wake Forest University
Written By: Kheira Bettir, University of Irvine, California for UroToday.com
at the 2017 AUA Annual Meeting - May 12 - 16, 2017 – Boston, Massachusetts, USA